Multiverse of phosphorglycerate kinase: Exploring canonical, moonlighting, and tumor microenvironmental functions

Han-Hsi Kuo1, Zhao-Jing He1, Phi Ngoc Tram2

  • 1Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Insights

Phosphoglycerate kinase (PGK) proteins have non-enzymatic roles in cancer, influencing tumor progression and the tumor microenvironment. Targeting these "moonlighting" functions offers new therapeutic strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Phosphoglycerate kinase (PGK) family members, PGK1 and PGK2, are known glycolytic enzymes.
  • Emerging evidence reveals diverse non-enzymatic 'moonlighting' functions for PGK1 and PGK2.
  • These functions are critical in cancer biology, impacting signaling, extracellular matrix, immunity, and metastasis.

Purpose of the Study:

  • To reevaluate the moonlighting functions of PGKs in tumor progression and the tumor microenvironment (TME).
  • To highlight PGKs' roles in extracellular signaling, stress adaptation, and immune evasion.
  • To integrate novel post-translational modifications of PGKs.

Main Methods:

  • Review of existing literature on PGK functions beyond canonical glycolysis.
  • Analysis of studies focusing on PGK's roles within the tumor microenvironment.
  • Integration of data on post-translational modifications of PGKs.

Main Results:

  • PGK1 and PGK2 exhibit context-dependent, spatially organized functions within the TME.
  • These proteins act as stress sensors and regulators of immune responses.
  • Evidence supports their involvement in extracellular signaling and immune evasion.

Conclusions:

  • PGKs possess significant non-enzymatic, cancer-promoting activities.
  • Targeting these moonlighting functions presents novel therapeutic opportunities.
  • Understanding PGK's multifaceted roles is crucial for cancer treatment strategies.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.8K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K